Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
NurExone Biologic: Erfahren Sie mehr über den Biotech-Gral!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EVGJ | ISIN: US1939391058 | Ticker-Symbol:
NASDAQ
09.05.24
21:57 Uhr
0,563 US-Dollar
-0,007
-1,26 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
COLLECTIVE AUDIENCE INC Chart 1 Jahr
5-Tage-Chart
COLLECTIVE AUDIENCE INC 5-Tage-Chart

Aktueller Chart COLLECTIVE AUDIENCE Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
COLLECTIVE AUDIENCE INC-Investoren interessieren sich auch für diese Wertpapiere
SOLIGENIX, INC.: FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus InfectionProvides MarVax Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON, N.J., April 15, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company)...
► Artikel lesen
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus InfectionProvides SuVax Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON, N.J., April 11, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company)...
► Artikel lesen
SOLIGENIX, INC.: Soligenix Announces Recent Accomplishments and Year End 2023 Financial ResultsPRINCETON, N.J., March 15, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...
► Artikel lesen
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial ResultsRADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported...
► Artikel lesen
XFRA 61Y: WIEDERAUFNAHME/RESUMPTIONFOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
XFRA 61Y: AUSSETZUNG/SUSPENSIONDAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILMARINUS PHARMAC....
► Artikel lesen
Volcon, Inc.: Volcon ePowersports Reports First Quarter 2024 Operational and Financial ResultsAUSTIN, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Volcon Inc. (NASDAQ: VLCN) ("Volcon', the "Company" or "we"), the first all-electric, off-road powersports company, today reported its operational...
► Artikel lesen
Volcon ePowersports, Inc.: Volcon ePowersports Reports First Quarter 2024 Operational and Financial ResultsAUSTIN, TX / ACCESSWIRE / May 7, 2024 / Volcon Inc. (NASDAQ:VLCN) ("Volcon', the "Company" or "we"), the first all-electric, off-road powersports company, today reported its operational highlights and...
► Artikel lesen
Volcon ePowersports, Inc.: Volcon ePowersports Reports 2023 Operational and Financial ResultsAUSTIN, TX / ACCESSWIRE / March 28, 2024 / Volcon Inc. (NASDAQ:VLCN) ("Volcon', the "Company" or "we"), the first all-electric, off-road powersports company, today reported its operational highlights...
► Artikel lesen